Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Potent and selective 5-HT1D agonists under development at MS&D

Sep. 19, 1997

Taisho/Nihon Nohyaku identify potent and selective D4 receptor ligands

Sep. 19, 1997

Janssen discloses new tachykinin antagonists

Sep. 19, 1997

Fournier presents new bradykinin antagonists

Sep. 19, 1997

Guilford presents preclinical results with PARP inhibitor

Sep. 19, 1997

Asta Medica and Wyeth-Ayerst agreement for epilepsy drug

Sep. 18, 1997

October launch for Zanaflex in U.K.

Sep. 18, 1997

Potent and selective N-type calcium channel blockers for stroke

Sep. 18, 1997

FDA panel recommends approval of Anesta's Actiq for cancer pain

Sep. 18, 1997

Anticonvulsant profile of two new GABA uptake inhibitors

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...